Coming soon: The EURas consortium grant agreement has now been signed, new recruitment will open soon
The European network for neurodevelopmental Rasopathies, consisting of 16 partners across Europe, is about to formally begin.
Our laboratory will be recruiting one researcher at postdoc or graduate student levels to identify robust phenotypic differences in neurons differentaited from human iPS cells representing each of 3 rare diseases – SynGAP, Cardio-Facio-Cutaneous syndrome and Costello Syndrome, These differences will be used develop a simple minaturised assay, which will be applied to a repurposing library to screen, identify and validate hits that could potentially see a rapid entry into clinical use.
A formal opening for a position will be posted soon.
Last updated on March 5, 2025
Recent Posts
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026
- Rector Widen Visited Our Centre Åbo Akademi University Rector, Gunilla Widén, visited our Centre on Wednesday, February 25th, to learn Read moreFebruary 27, 2026
- Laura Elo is awarded the Leif C. Groop Award for outstanding research on type 1 diabetesLaura Elo a group leader at Turku Bioscience is awarded the Leif C. Groop Award Read moreFebruary 23, 2026
- Finnish Cultural Foundation Awards Funding to Turku Bioscience ResearchersWe are pleased to announce recent funding from The Finnish Cultural Foundation: Congratulations to all Read moreFebruary 16, 2026